CompoAtlas

Desmodium

Desmodium, licence 80084457: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Natural health product licensed in Canada

Licence holder
Les Laboratoires Oxus Inc.
NPN or DIN-HM
80084457
Status
Active licence
Licence date
13 April 2018
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Desmodium styracifolium

Source : Sommité (herbe)

Extract : Matériel brut sec

Extraction ratio : 4:1

Dry plant equivalent : 180 mg

45.0 mgNot calculated
Curcuma longa

Source : Racine

Extract : Matériel brut sec

Extraction ratio : 20:1

Dry plant equivalent : 1000 mg

50.0 mgNot calculated
Gentiana lutea

Source : Racine

Extract : Matériel brut sec

Extraction ratio : 4:1

Dry plant equivalent : 120 mg

30.0 mgNot calculated
Silybum marianum

Source : Graine(s)

Extract : Matériel brut sec

Extraction ratio : 4:1

Dry plant equivalent : 206 mg

Potency : 55.0 mg Silymarine

65.0 mgNot calculated
Silybum marianum

Source : Fruit

Extract : Matériel brut sec

Extraction ratio : 4:1

Dry plant equivalent : 206 mg

Potency : 55.0 mg Silymarine

65.0 mgNot calculated
Chrysanthellum americanum

Source : Plante entière

Extract : Matériel brut sec

Extraction ratio : 5:1

Dry plant equivalent : 225 mg

45.0 mgNot calculated

Non-medicinal ingredients

Hypromellose, Stéarate de magnésium

PopulationAgeQuantity per servingFrequency
Adultesminimum: 19.0 Année(s)1.0 Capsule3.0 Tous les jours

Uses authorised in Canada

Le chardon-Marie est traditionnellement utilisé en phytothérapie comme agent hépatoprotecteur (protecteur du foie). Utilisé en phytothérapie pour aider à soulager les troubles de digestion/la dyspepsie.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80084457

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line